LB Pharmaceuticals Inc Common Stock (LBRX) Earnings Analysis
LB Pharmaceuticals Inc Common Stock (LBRX) has no confirmed upcoming earnings date. Last quarter (2026-03-26) it beat with EPS -0.45 USD vs -0.45 USD est (0%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -1.67.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LBRX next report earnings?
No confirmed upcoming earnings date is currently scheduled for LBRX. This page updates as the calendar is published.
LBRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -0.45 USD | -0.45 USD | 0% | Beat |
| 2025-11-06 | -0.61 USD | -0.57 USD | -7% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
LBRX valuation and analyst view
| Trailing P/E | -1.67 |
|---|---|
| Trailing EPS | -1.38697 USD |
| Price / book | 2.67 |
| Dividend yield | 0.00% |
| Market cap | 1.01B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
| Avg price target | 43.25 USD |
Related research pages
Frequently asked questions
When is LB Pharmaceuticals Inc Common Stock (LBRX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for LBRX. This page updates as the calendar is published.
Did LBRX beat earnings last quarter?
In its 2026-03-26 report, LBRX posted EPS of -0.45 USD versus a -0.45 USD estimate — a beat of 0%.
What is LBRX's earnings track record?
Over the last 2 reported quarters with consensus data, LBRX beat estimates 1 times (50%).
What is LBRX's current P/E ratio and EPS?
LBRX trades at a trailing P/E of -1.67 on trailing EPS of -1.3869738228586161 USD.
What do analysts rate LBRX?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 43.25 USD.